Home›Iopromide

Iopromide

Also known as: Ultravist

Radiographic Contrast AgentX-Ray Contrast Activity

Route: Intra-Arterial, Intravenous

2 interactions on record⛔ Black Box Warning

Iopromide has 2 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Metformin, Radioactive Iodine. Patients taking Iopromide should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 2
Major: 1
Moderate: 1

Major (1)

Iopromide + Metformin— Iodinated contrast agents increase risk of metformin-induced lactic acidosis, possibly by worsening renal function. Stop…

Moderate (1)

Iopromide + Radioactive Iodine— IOPROMIDE may interfere with thyroid uptake of radioactive iodine (I-131 and I-123), decreasing therapeutic and diagnost…

Iopromide + Metformin⚠️Major

Iodinated contrast agents increase risk of metformin-induced lactic acidosis, possibly by worsening renal function. Stop metformin at or prior to IOPROMIDE administration in patients with eGFR 30-60 mL/min/1.73 m2, hepatic impairment, alcoholism, heart failure, or intra-arterial contrast use.

Iopromide + Radioactive Iodine🟡Moderate

IOPROMIDE may interfere with thyroid uptake of radioactive iodine (I-131 and I-123), decreasing therapeutic and diagnostic efficacy. Avoid thyroid therapy or testing for up to 6 weeks post-IOPROMIDE.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.